Hyundai Bioscience Market Cap

Hyundai Bioscience has a market cap or net worth of 482.11 billion as of June 27, 2025. Its market cap has decreased by -42.07% in one year.

Market Cap

482.11B

Enterprise Value

426.26B

Revenue

10.71B

Ranking

n/a

PE Ratio

n/a

Stock Price

8,820.00

Market Cap Chart

Since March 3, 2003, Hyundai Bioscience's market cap has increased from 47.49B to 482.11B, an increase of 915.10%. That is a compound annual growth rate of 10.95%.

Market Cap History

Date	Market Cap	% Change
Jun 18, 2025	482.11B	-14.19%
Dec 30, 2024	561.85B	-45.92%
Dec 28, 2023	1,038.98B	-4.44%
Dec 29, 2022	1,087.24B	11.39%
Dec 30, 2021	976.10B	-6.92%
Dec 30, 2020	1,048.68B	115.45%
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro
Dec 28, 2017	Pro	Pro
Dec 29, 2016	Pro	Pro
Dec 30, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	71.10T
Celltrion	35.38T
ALTEOGEN	20.57T
Yuhan	7,588.59B
SK Biopharmaceuticals	7,196.99B
HLB Co., Ltd.	6,283.13B
PharmaResearch	5,189.63B
Peptron	4,822.55B

Market Cap Rankings